SCHEMBL960027

SCHEMBL960027

COC(=O)c1cccc(-c2cc(-c3ccc(CO)cc3)on2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD1 Q15139 7/20 0.51
PPARG P37231 2/20 0.49
PPARA Q07869 2/20 0.49
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
PRKD3 O94806 1/20 0.45
PRKD2 Q9BZL6 1/20 0.45
CYP4F2 P78329 1/20 0.45
CYP4A11 Q02928 1/20 0.45
CXCR1 P25024 2/20 0.45
CA12 O43570 2/20 0.44
CA9 Q16790 2/20 0.44
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5209891 0.87 NPC1 (0.57) PPARGPPARATP53MAPTNPC1
SCHEMBL937517 0.86 NPC1 (0.59) PRKD1PPARGPPARATP53MAPT
SCHEMBL959372 0.86 TP53 (0.65) PRKD1PPARGPPARATP53MAPT
SCHEMBL12171384 0.85 NPC1 (0.52) PRKD1PPARGPPARATP53MAPT
SCHEMBL1505201 0.85 NPC1 (0.58) PPARGPPARATP53MAPTNPC1
SCHEMBL12171803 0.85 NPC1 (0.65) TP53MAPTNPC1RAB9A
SCHEMBL6923210 0.85 NPC1 (0.50) PRKD1PPARGPPARAMAPTNPC1
SCHEMBL960012 0.84 NPC1 (0.52) PRKD1PPARGPPARATP53MAPT
SCHEMBL12171462 0.84 MAPT (0.53) PPARGPPARATP53MAPTNPC1
SCHEMBL937384 0.83 ALDH1A1 (0.51) PRKD1PPARGPPARATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011009484-A1 ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS NOVARTIS AG (CH) 2011-01-27 WO disclosed
WO-2011009484-A1 ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS NOVARTIS AG (CH) 2011-01-27 WO disclosed